Mia - MIA SH3 domain containing Gene

Also Known as Mia1; Cdrap; CD-RAP

Species: Mus musculus

Gene Type: protein coding
Gene ID: 12587

Summary

Predicted to enable growth factor activity. Acts upstream of or within cell-matrix adhesion and extracellular matrix organization. Predicted to be located in extracellular region. Is expressed in several structures, including articular cartilage; autopod; respiratory system; sensory organ; and skeleton. Orthologous to human MIA (MIA SH3 domain containing). [provided by Alliance of Genome Resources, Apr 2022]

Mia Products (1)

mRNA Protein Name
NM_019394.3 NP_062267.2 melanoma-derived growth regulatory protein precursor

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence Références Source
acts upstream of or within cell-matrix adhesion IMP
IMP: Inferred from mutant phenotype
11839810 MGI
acts upstream of or within extracellular matrix organization IMP
IMP: Inferred from mutant phenotype
11839810 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

melanoma-derived growth regulatory protein

  • cartilage-derived retinoic acid-sensitive protein

  • melanoma inhibitory activity 1

  • melanoma inhibitory activity protein

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (1)
Cat. No. Nom du produit Effect
Pureté Rare Diseases
HY-130149 Adagrasib Inhibitor 99.96% Unkown

Clinical Phase

Bioactive Molecules (8)
Cat. No. Nom du produit Effect
Pureté Phase
HY-13594 Chlorin e6 99.51% Phase 3
HY-112089 Naporafenib Inhibitor 99.92% Phase 3
HY-160023 Elisrasib 99.68% Phase 2
HY-17617 Nastorazepide 99.95% Phase 2
HY-145622 Mecbotamab vedotin Inhibitor 99.11% Phase 2
HY-13323 CX-5461 Inhibitor 99.67% Phase 1
HY-145926 MRTX0902 Inhibitor 99.67% Phase 1
HY-148012 SOP1812 98.46% Phase 1

Pre-clinical Phase

Bioactive Molecules (133)
Cat. No. Nom du produit
Effect
Pureté
Rare Diseases
HY-13323A CX-5461 dihydrochloride Inhibitor 99.41% Unkown
HY-100367 ES 936 Inhibitor 98.66% Unkown
HY-33878 2-PPA Inhibitor 99.98% Unkown
HY-164899 2A3 99.92% Unkown
HY-N0841 Bruceine A 99.89% Unkown
HY-145321 TMX-4100 Inhibitor 98.26% Unkown
HY-156716 MASTL-IN-2 Inhibitor 98.89% Unkown
HY-112776A BN82002 hydrochloride Inhibitor 99.36% Unkown
HY-128522 ARS-1323-alkyne Inhibitor 99.59% Unkown
HY-114189 GW284543 Inhibitor 99.94% Unkown
HY-165245 SBI-183 Inhibitor 99.8% Unkown
HY-W115529 Geranic acid Inhibitor 90.0% Unkown
HY-144310 DX3-213B Inhibitor 99.68% Unkown
HY-155874 ZNL-05-044 Inhibitor 99.11% Unkown
HY-177106 ADT-1004 Inhibitor 98.16% Unkown
HY-141477 RM-018 Inhibitor 95.95% Unkown
HY-146459 Akt1-IN-1 Inhibitor 99.77% Unkown
HY-155356 YN14 Degrader 99.08% Unkown
HY-157762 GPX4-IN-9 99.18% Unkown
HY-162014 WDR5 degrader-1 Degrader 98.00% Unkown
HY-154313 Spiclomazine Inhibitor 99.56% Unkown
HY-162629 LDHA-IN-7 Inhibitor 99.59% Unkown
HY-163299 pan-KRAS-IN-5 96.70% Unkown
HY-178194 SHY-855 Inhibitor 98.54% Unkown
HY-N8284 Tomentosin 98.95% Unkown
HY-W140346 Copper(II) pyrithione Inhibitor 97.62% Unkown
HY-112776 BN82002 Inhibitor / Unkown
HY-137046 Nek2-IN-4 / Unkown
HY-153090 Transketolase-IN-4 Inhibitor 99.29% Unkown
HY-161618 MJ04 Inhibitor 98.08% Unkown
HY-161767 JWJ-01-306 Inhibitor / Unkown
HY-176798 NCI-006 98.73% Unkown
HY-178211 SHY-867 Inhibitor 99.66% Unkown
HY-P11781B Cys-HW12 TFA 87.29% Unkown
HY-146544 KRAS inhibitor-14 Inhibitor / Unkown
HY-146546 KRAS inhibitor-16 Inhibitor / Unkown
HY-108436 Deltazinone 1 Inhibitor 98.79% Unkown
HY-111033 RO5068760 / Unkown
HY-114189A GW284543 hydrochloride Inhibitor / Unkown
HY-120825 QD 232 / Unkown
HY-120966 NCX 2121 Inhibitor / Unkown
HY-122152 Spiclomazine hydrochloride Inhibitor / Unkown
HY-123009 KCN1 / Unkown
HY-123597 NSC 109555 / Unkown
HY-125472 LC-1028 Inhibitor / Unkown
HY-142946 KRAS G12C inhibitor 44 Inhibitor / Unkown
HY-144311 OXPHOS-IN-1 Inhibitor / Unkown
HY-146475 KRAS inhibitor-17 Inhibitor / Unkown
HY-146476 KRAS inhibitor-18 Inhibitor / Unkown
HY-146533 KRAS inhibitor-12 Inhibitor / Unkown
HY-146537 KRAS G12C inhibitor 47 Inhibitor / Unkown
HY-146543 KRAS inhibitor-13 Inhibitor / Unkown
HY-146545 KRAS inhibitor-15 Inhibitor / Unkown
HY-147838 Nampt-IN-9 Inhibitor / Unkown
HY-149076 hGAPDH-IN-1 / Unkown
HY-149510 MET/PDGFRA-IN-1 / Unkown
HY-149511 MET/PDGFRA-IN-2 / Unkown
HY-149607 SHP2-IN-22 Inhibitor / Unkown
HY-150400 XF056-132 free base Degrader / Unkown
HY-150400A XF056-132 Degrader / Unkown
HY-151968 KRAS G12C inhibitor 57 Inhibitor / Unkown
HY-153505 ADAMTS-4/5-IN-1 Inhibitor / Unkown
HY-155065 SB-1295 / Unkown
HY-155356A YN14 (mixture of diastereomers) / Unkown
HY-156549 KRAS G12C inhibitor 61 Inhibitor / Unkown
HY-159511 Hedgehog IN-7 Inhibitor / Unkown
HY-159570 XD2-149 / Unkown
HY-159577 Nic-15 Modulator / Unkown
HY-161320 EGFR-IN-105 / Unkown
HY-161425 Antitumor agent-149 Inducer / Unkown
HY-161858 EpskA21 / Unkown
HY-162281 PROTAC SOS1 degrader-6 / Unkown
HY-162627 LDHA-IN-6 Inhibitor / Unkown
HY-162763 FLQY2 Inducer / Unkown
HY-162873 MEK/RAF-IN-1 Inhibitor / Unkown
HY-164445 STAT3-IN-32 Inhibitor / Unkown
HY-168577 KRAS G12D inhibitor 25 / Unkown
HY-168716 SOS1-IN-17 Inhibitor / Unkown
HY-170550 KRAS G12C inhibitor 69 Inhibitor / Unkown
HY-170958 Scr-IN-1 / Unkown
HY-170965 Anticancer agent 264 Inhibitor / Unkown
HY-171745 ATR-IN-32 Inhibitor / Unkown
HY-172210 DDO-8958 Inducer / Unkown
HY-172259 Toyaburgine Inhibitor / Unkown
HY-173047 KRASG12C IN-15 Inhibitor / Unkown
HY-173145 CD13-IN-1 Inhibitor / Unkown
HY-173250 YN14-H / Unkown
HY-173253 E3 Ligase Ligand-linker Conjugate 173 / Unkown
HY-173477 JR5-26B Inducer / Unkown
HY-175230 ZG-2492 / Unkown
HY-175326 SOS1-IN-21 Inhibitor / Unkown
HY-179119 AB19 Inhibitor / Unkown
HY-179157 MA203 / Unkown
HY-179158 CHK1-IN-15 Ligand / Unkown
HY-179577 PIN1 degrader-3 Degrader / Unkown
HY-181071 POLRMT-IN-3 / Unkown
HY-181072 POLRMT-IN-4 Inhibitor / Unkown
HY-181913 KRAS G12C-IN-76 Inhibitor / Unkown
HY-181965 KRAS G12C-IN-78 Inhibitor / Unkown
HY-182044 MRTX849-amide-C4-(o)-carborane / Unkown
HY-183257 ATI-1 / Unkown
HY-183674 MEK-IN-10 / Unkown
HY-183786 Anticancer agent 327 / Unkown
HY-183984 G-quadruplex ligand 6 Ligand / Unkown
HY-184148 PFKFB3-IN-3 Inhibitor / Unkown
HY-184245 Hsp90-IN-48 Inhibitor / Unkown
HY-184708 Les-6666 / Unkown
HY-184984 SN-38-A2 Degrader / Unkown
HY-D2380 H2S probe 1 / Unkown
HY-DY1092 Chlorin e6 (solution) / Unkown
HY-N17236 Forsyshiyanine A Inhibitor / Unkown
HY-N19463 Dicatenarin / Unkown
HY-P10783 BGC0222 Modulator / Unkown
HY-P11781 HW12 Control / Unkown
HY-P11781A Cys-HW12 / Unkown
HY-P2698 1-Alaninechlamydocin / Unkown
HY-RS08419 MIA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS08420 MIA2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS08421 MIA3 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W100150 N-((6-Methylpyridin-2-yl)carbamothioyl)benzamide / Unkown
HY-141652 N-2-Azidoethyl betulonamide / Unkown
HY-160121 Patrinoside aglucone Inhibitor / Unkown
HY-164039 Talorasib / Unkown
HY-170527 Anticancer agent 260 / Unkown
HY-181250 SHP2-IN-46 Inhibitor / Unkown
HY-183400 BIM-46174 / Unkown
HY-184378 MDB5 / Unkown
HY-50693 5-CITEP / Unkown
HY-RS16950 Mia Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19362 Otor Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS21376 Mia2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23393 Mia Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS27895 Mia2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Mia NCBI NCBI:8190